Blackboxstocks (BLBX) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Voting matters and shareholder proposals
Election of five directors to serve one-year terms expiring at the 2025 annual meeting and until successors are elected and qualified.
Ratification of Turner, Stone & Company, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
Consideration of any other business properly brought before the meeting or any adjournment or postponement.
Board of directors and corporate governance
Board recommends voting in favor of all listed director nominees and proposals.
Audit committee and external auditor matters
Audit Committee selected Turner, Stone & Company, L.L.P. as the independent auditor for the upcoming fiscal year.
Ratification of the auditor is a key agenda item for shareholder approval.
Partial view of Summaries dataset, powered by Quartr API
Latest events from Blackboxstocks
- 2025 revenue fell 5.3% and net loss widened as the company advanced a transformative merger.BLBX
Q4 202523 Feb 2026 - Shareholders will vote on director elections and auditor ratification, with major voting power held by the CEO.BLBX
Proxy Filing16 Dec 2025 - Resale registration for 920,000 shares tied to a $2.3M debenture amid a transformative merger.BLBX
Registration Filing16 Dec 2025 - 526,800 shares registered for resale amid a pending merger and no proceeds to the company.BLBX
Registration Filing16 Dec 2025 - Plans to raise up to $50M via flexible offerings to fund SaaS platform growth for retail traders.BLBX
Registration Filing16 Dec 2025 - Director nominee Ray Balestri's passing leaves a Board vacancy for the 2024 Annual Meeting.BLBX
Proxy Filing2 Dec 2025 - Stockholders will elect five directors and ratify the auditor at the 2024 virtual annual meeting.BLBX
Proxy Filing2 Dec 2025 - Shareholders will vote on director elections and auditor ratification, with the CEO holding majority voting power.BLBX
Proxy Filing2 Dec 2025 - Q3 2025 saw higher revenue but ongoing losses and significant uncertainty pending a key merger.BLBX
Q3 202516 Oct 2025